Fig 1.
Study cohort with groups and subgroups.
N: number of patients; S: Endoscopic Tumor Length < 3 cm; L: Endoscopic Tumor Length ≥ 3 cm; SCC: squamous cell carcinoma; AC: adenocarcinoma.
Table 1.
Cohort demographics, clinical and pathological characteristics.
Fig 2.
5-year survival according to endoscopic tumor length (ETL).
SCC: squamocellular carcinoma; AC: adenocarcinoma; S: ETL < 3 cm; L: ETL ≥ 3 cm.
Table 2.
Univariate 5-year survival analysis.
Fig 3.
5-year survival for stage 0-II SCC patients, with negative lymph nodes, according to endoscopic tumor length (ETL).
SCC: squamocellular carcinoma; ETL: endoscopic tumor length; S: ETL < 3 cm; L: ETL ≥ 3 cm.
Table 3.
Multivariate analysis.
Table 4.
Recent tumor length studies identifying a prognostic significant cutoff.